|
PART I FOUNDATIONS: BASIC SCIENCES AND REAGENTS |
|
|
|
Chapter 1 Immunology: Basic Principles and Applications in the Blood Bank |
|
|
1 | (27) |
|
Section 1 Characteristics Associated With Antigen-Antibody Reactions |
|
|
2 | (8) |
|
General Properties of Antigens |
|
|
2 | (1) |
|
General Properties of Antibodies |
|
|
3 | (1) |
|
|
3 | (2) |
|
|
5 | (1) |
|
Comparison of IgM and IgG Antibodies |
|
|
5 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
Primary and Secondary Immune Response |
|
|
7 | (1) |
|
Antigen-Antibody Reactions |
|
|
8 | (1) |
|
Properties That Influence Binding |
|
|
8 | (2) |
|
Section 2 Characteristics Associated With Red Cell Antigen-Antibody Reactions |
|
|
10 | (9) |
|
|
10 | (2) |
|
|
12 | (1) |
|
Immunohematology: Antigen-Antibody Reactions In Vivo |
|
|
12 | (1) |
|
Transfusion, Pregnancy, and the Immune Response |
|
|
12 | (1) |
|
|
12 | (2) |
|
Clearance of Antigen-Antibody Complexes |
|
|
14 | (1) |
|
Immunohematology: Antigen-Antibody Reactions In Vitro |
|
|
14 | (1) |
|
Overview of Agglutination |
|
|
14 | (1) |
|
Sensitization Stage or Antibody Binding to Red Cells |
|
|
14 | (1) |
|
Factors Influencing First Stage of Agglutination |
|
|
15 | (1) |
|
Lattice-Formation Stage or Cell-Cell Interactions |
|
|
16 | (1) |
|
Factors Influencing Second Stage of Agglutination |
|
|
16 | (1) |
|
Grading Agglutination Reactions |
|
|
17 | (1) |
|
Hemolysis as an Indicator of Antigen-Antibody Reactions |
|
|
18 | (1) |
|
Section 3 Human Leukocyte Antigen (Hla) System And Platelet Immunology |
|
|
19 | (9) |
|
|
19 | (1) |
|
Testing Applications in the Clinical Laboratory |
|
|
19 | (1) |
|
Inheritance and Nomenclature of HLA |
|
|
19 | (2) |
|
Testing and Identification of HLA and Antibodies |
|
|
21 | (1) |
|
Hematopoietic Progenitor Cell Transplants |
|
|
22 | (1) |
|
Graft-versus-Host Disease |
|
|
23 | (1) |
|
|
23 | (5) |
|
Chapter 2 Blood Banking Reagents: Overview and Applications |
|
|
28 | (31) |
|
Section 1 Introduction To Routine Testing In Immunohematology |
|
|
29 | (2) |
|
Sources of Antigen for Testing |
|
|
29 | (1) |
|
Sources of Antibody for Testing |
|
|
30 | (1) |
|
Routine Testing Procedures in the Immunohematology Laboratory |
|
|
30 | (1) |
|
Section 2 Introduction To Blood Banking Reagents |
|
|
31 | (1) |
|
Regulation of Reagent Manufacture |
|
|
31 | (1) |
|
|
32 | (1) |
|
Section 3 Commercial Antibody Reagents |
|
|
32 | (6) |
|
Polyclonal versus Monoclonal Antibody Products |
|
|
32 | (1) |
|
Polyclonal Antibody Reagents |
|
|
33 | (1) |
|
Monoclonal Antibody Reagents |
|
|
33 | (1) |
|
Monoclonal and Polyclonal Antibody Reagents |
|
|
34 | (1) |
|
Reagents for ABO Antigen Typing |
|
|
34 | (2) |
|
Reagents for D Antigen Typing |
|
|
36 | (1) |
|
Low-Protein Reagent Control |
|
|
37 | (1) |
|
Section 4 Reagent Red Cells |
|
|
38 | (2) |
|
A1 and B Red Cells for ABO Serum Testing |
|
|
38 | (1) |
|
|
39 | (1) |
|
Antibody Identification Panel Cells |
|
|
40 | (1) |
|
Section 5 Antiglobulin Test And Reagents |
|
|
40 | (7) |
|
Principles of Antiglobulin Test |
|
|
40 | (2) |
|
|
42 | (1) |
|
Indirect Antiglobulin Test |
|
|
43 | (1) |
|
Sources of Error in Antiglobulin Testing |
|
|
43 | (1) |
|
|
44 | (1) |
|
Polyspecific Antihuman Globulin Reagents |
|
|
45 | (1) |
|
Monospecific Antihuman Globulin Reagents |
|
|
45 | (1) |
|
|
46 | (1) |
|
Section 6 Principles Of Antibody Potentiators And Lectins |
|
|
47 | (2) |
|
Low-Ionic-Strength Saline (LISS) |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
Section 7 Other Methods Of Detecting Antigen-Antibody Reactions |
|
|
49 | (10) |
|
|
49 | (1) |
|
Microplate Testing Methods |
|
|
50 | (2) |
|
Solid-Phase Red Cell Adherence Methods |
|
|
52 | (7) |
|
Chapter 3 Genetic Principles in Blood Banking |
|
|
59 | (18) |
|
Section 1 Blood Group Cenetics |
|
|
60 | (7) |
|
|
60 | (1) |
|
Phenotype versus Genotype |
|
|
61 | (1) |
|
|
61 | (1) |
|
Genes, Alleles, and Polymorphism |
|
|
61 | (1) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
Heterozygosity and Homozygosity |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
Section 2 Populatoin Genetics |
|
|
67 | (2) |
|
Combined Phenotype Calculations |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
Section 3 Molecular Genetics |
|
|
69 | (8) |
|
Application of Molecular Genetics to Blood Banking |
|
|
69 | (1) |
|
Polymerase Chain Reaction |
|
|
70 | (1) |
|
Polymerase Chain Reaction-Based Human Leukocyte Antigen Typing Procedures |
|
|
70 | (2) |
|
Molecular Testing Applications in Red Cell Typing |
|
|
72 | (1) |
|
Polymerase Chain Reaction-Based Red Cell Typing Procedures |
|
|
72 | (5) |
|
PART II OVERVIEW OF THE MAJOR BLOOD GROUPS |
|
|
|
Chapter 4 ABO and H Blood Group Systems and Secretor Status |
|
|
77 | (30) |
|
Section 1 Historical Overview Of Abo Blood Group System |
|
|
79 | (1) |
|
Section 2 Abo And H Blood Group System Antigens |
|
|
80 | (6) |
|
General Characteristics of ABO Antigens |
|
|
80 | (1) |
|
Inheritance and Development of A, B, and H Antigens |
|
|
81 | (1) |
|
Common Structure for A, B, and H Antigens |
|
|
82 | (1) |
|
|
82 | (1) |
|
Development of A and B Antigens |
|
|
82 | (2) |
|
|
84 | (1) |
|
Comparison of A1 and A2 Phenotypes |
|
|
84 | (1) |
|
Additional Subgroups of A and B |
|
|
85 | (1) |
|
Importance of Subgroup Identification in Donor Testing |
|
|
86 | (1) |
|
Section 3 Genetic Features Of Abo Blood Group System |
|
|
86 | (2) |
|
Section 4 Abo Blood Groups System Antibodes |
|
|
88 | (1) |
|
General Characteristics of Human Anti-A and Anti-B |
|
|
88 | (1) |
|
|
88 | (1) |
|
Hemolytic Properties and Clinical Significance |
|
|
88 | (1) |
|
In Vitro Serologic Reactions |
|
|
89 | (1) |
|
Human Anti-A,B from Group O Individuals |
|
|
89 | (1) |
|
|
89 | (1) |
|
Section 5 Abo Blood Group System And Transfusion |
|
|
89 | (2) |
|
|
89 | (1) |
|
Selection of ABO-Compatible Red Blood Cells and Plasma Products for Transfusion |
|
|
90 | (1) |
|
Section 6 Recognition And Resolution Of Abo Discrepancies |
|
|
91 | (9) |
|
Technical Considerations in ABO Phenotyping |
|
|
91 | (1) |
|
Sample-Related ABO Discrepancies |
|
|
92 | (1) |
|
ABO Discrepancies Associated with Red Cell Testing |
|
|
92 | (4) |
|
ABO Discrepancies Associated with Serum or Plasma Testing |
|
|
96 | (4) |
|
Section 7 Special Topics Related To Abo And H Blood Group Systems |
|
|
100 | (7) |
|
|
100 | (1) |
|
|
101 | (6) |
|
Chapter 5 Rh Blood Group System |
|
|
107 | (19) |
|
Section 1 Historical Overview Of The Discovery Of The D Antigen |
|
|
108 | (1) |
|
Section 2 Genetics, Biochemistry, And Terminology |
|
|
108 | (4) |
|
Fisher-Race: CDE Terminology |
|
|
110 | (1) |
|
Wiener: Rh-Hr Terminology |
|
|
110 | (1) |
|
Rosenfield: Numeric Terminology |
|
|
111 | (1) |
|
International Society of Blood Transfusion: Standardized Numeric Terminology |
|
|
111 | (1) |
|
Determining the Genotype from the Phenotype |
|
|
111 | (1) |
|
Section 3 Antigens Of The Rh Blood Group System |
|
|
112 | (7) |
|
|
112 | (1) |
|
|
112 | (3) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (1) |
|
Significance of Testing for Weak D |
|
|
116 | (1) |
|
Other Rh Blood Group System Antigens |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
Hemolytic Disease of the Fetus and Newborn |
|
|
120 | (1) |
|
Section 5 Lw Blodd Group System |
|
|
120 | (6) |
|
Relationship to the Rh Blood Group System |
|
|
120 | (6) |
|
Chapter 6 Other Blood Group Systems |
|
|
126 | (32) |
|
Section 1 Why Study Other Blood Group Systems? |
|
|
127 | (2) |
|
|
127 | (2) |
|
Section 2 Kell Blood Group System |
|
|
129 | (3) |
|
Characteristics and Biochemistry of Kell Antigens |
|
|
129 | (1) |
|
|
129 | (1) |
|
Biochemistry of Kell Antigens |
|
|
129 | (1) |
|
Immunogenicity of Kell Antigens |
|
|
130 | (1) |
|
|
130 | (1) |
|
Genetics of Kell Blood Group System |
|
|
131 | (1) |
|
Characteristics of Kell Antibodies |
|
|
131 | (1) |
|
Section 3 Kx Blood Group System |
|
|
132 | (2) |
|
KX Antigen and Its Relationship to Kell Blood Group System |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
133 | (1) |
|
Section 4 Duffy Blood Group System |
|
|
134 | (2) |
|
Characteristics and Biochemistry of Duffy Antigens |
|
|
134 | (1) |
|
|
134 | (1) |
|
Biochemistry of Duffy Antigens |
|
|
134 | (1) |
|
Genetics of Duffy Blood Group System |
|
|
135 | (1) |
|
Characteristics of Duffy Antibodies |
|
|
135 | (1) |
|
|
136 | (1) |
|
Section 5 Kidd Blood Group System |
|
|
136 | (2) |
|
Characteristics and Biochemistry of Kidd Antigens |
|
|
136 | (1) |
|
|
136 | (1) |
|
Biochemistry of Kidd Antigens |
|
|
136 | (1) |
|
Genetics of Kidd Blood Group System |
|
|
137 | (1) |
|
Characteristics of Kidd Antibodies |
|
|
137 | (1) |
|
Section 6 Lutheran Blood Group System |
|
|
138 | (2) |
|
Characteristics And Biochemistry of Lutheran Antigens |
|
|
138 | (1) |
|
|
138 | (1) |
|
Biochemistry of Lutheran Antigens |
|
|
139 | (1) |
|
Genetics of Lutheran Blood Group System |
|
|
139 | (1) |
|
Characteristics of Lutheran Antibodies |
|
|
139 | (1) |
|
|
139 | (1) |
|
|
139 | (1) |
|
Section 7 Lewis Blood Group System |
|
|
140 | (2) |
|
Characteristics and Biochemistry of Lewis Antigens |
|
|
140 | (1) |
|
|
140 | (1) |
|
Biochemistry of Lewis Antigens |
|
|
140 | (1) |
|
Inheritance of Lewis System Antigens |
|
|
141 | (1) |
|
Characteristics of Lewis Antibodies |
|
|
142 | (1) |
|
Serologic Characteristics |
|
|
142 | (1) |
|
Section 8 I Blood Group System And I Antigen |
|
|
142 | (2) |
|
|
143 | (1) |
|
Biochemistry of I and i Antigens |
|
|
143 | (1) |
|
Serologic Characteristics of Autoanti-I |
|
|
143 | (1) |
|
|
144 | (1) |
|
Section 9 P1 Pk Blood Group System, Globoside Blood Group System, And Globoside Blood Group Collection |
|
|
144 | (3) |
|
|
144 | (1) |
|
|
144 | (1) |
|
P1PK and GLOB Blood Group System Antigens Facts |
|
|
144 | (1) |
|
|
145 | (1) |
|
P1PK and GLOB Blood Group System Antibodies |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
147 | (1) |
|
Section 10 Mns Blood Group System |
|
|
147 | (3) |
|
|
147 | (1) |
|
|
148 | (1) |
|
Genetics and Biochemistry |
|
|
148 | (1) |
|
|
148 | (1) |
|
GPB: S, s, and U Antigens |
|
|
148 | (1) |
|
Antibodies of MNS Blood Group System |
|
|
148 | (1) |
|
|
149 | (1) |
|
|
150 | (1) |
|
Anti-S, Anti-s, and Anti-U |
|
|
150 | (1) |
|
Section 11 Miscellaneous Blood Group Systems |
|
|
150 | (8) |
|
PART III ESSENTIALS OF PRETRANSFUSION TESTING |
|
|
|
Chapter 7 Antibody Detection and Identification |
|
|
158 | (30) |
|
Section 1 Antibody Detection |
|
|
159 | (3) |
|
|
159 | (1) |
|
Autocontrol and Direct Antiglobulin Test |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
Section 2 Antibody Identification |
|
|
162 | (12) |
|
|
162 | (1) |
|
Panel Interpretation: Single Antibody Specificity |
|
|
163 | (2) |
|
|
165 | (1) |
|
|
165 | (1) |
|
|
165 | (1) |
|
|
165 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (2) |
|
Multiple Antibody Resolution |
|
|
168 | (1) |
|
|
168 | (1) |
|
Antibodies to High-Frequency Antigens |
|
|
169 | (1) |
|
|
170 | (1) |
|
High-Titer, Low-Avidity Antibodies |
|
|
170 | (1) |
|
Antibodies to Low-Frequency Antigens |
|
|
171 | (1) |
|
Enhancing Weak IgG Antibodies |
|
|
171 | (1) |
|
|
172 | (2) |
|
|
174 | (14) |
|
|
174 | (1) |
|
|
175 | (1) |
|
Avoiding Cold Autoantibody Reactivity |
|
|
176 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
178 | (1) |
|
|
178 | (2) |
|
|
180 | (8) |
|
Chapter 8 Compatibility Testing |
|
|
188 | (20) |
|
Section 1 Princeples Of The Crossmatch |
|
|
190 | (4) |
|
|
190 | (1) |
|
Purposes of Crossmatch Testing |
|
|
191 | (1) |
|
Standards and Regulations Governing the Crossmatch |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
Limitations of Crossmatch Testing |
|
|
193 | (1) |
|
Problem Solving Incompatible Crossmatches |
|
|
194 | (1) |
|
Section 2 Principles Of Comaptibility Testing |
|
|
194 | (5) |
|
Overview of Steps in Compatibility Testing |
|
|
194 | (1) |
|
|
194 | (2) |
|
Comparison with Previous Records |
|
|
196 | (1) |
|
Repeat Testing of Donor Blood |
|
|
196 | (1) |
|
Pretransfusion Testing on Recipient Sample |
|
|
197 | (1) |
|
Tagging, Inspecting, Issuing, and Transfusing Blood Products |
|
|
198 | (1) |
|
|
199 | (9) |
|
Urgent Requirement for Blood and Blood Components |
|
|
199 | (2) |
|
|
201 | (1) |
|
Maximum Surgical Blood Order Schedule |
|
|
201 | (1) |
|
Type and Screen Protocols |
|
|
201 | (1) |
|
Crossmatching Autologous Blood |
|
|
202 | (1) |
|
Crossmatching of Infants Younger than 4 Months Old |
|
|
202 | (1) |
|
Pretransfusion Testing for Non-Red Blood Cell Products |
|
|
203 | (5) |
|
Chapter 9 Blood Bank Automation for Transfusion Services |
|
|
208 | (18) |
|
Section 1 Introduction To Automation In Immunohematology |
|
|
208 | (3) |
|
Forces Driving the Change to Automation |
|
|
209 | (1) |
|
Benefits and Barriers of Automated Instruments |
|
|
209 | (1) |
|
|
209 | (1) |
|
|
210 | (1) |
|
Characteristics of an Ideal Instrument for the Blood Bank |
|
|
211 | (1) |
|
Section 2 Selection Of Automation To Meet Laboratory Needs |
|
|
211 | (2) |
|
|
211 | (1) |
|
Base Technology Assessment |
|
|
212 | (1) |
|
|
212 | (1) |
|
Section 3 Automated Testing Systems |
|
|
213 | (13) |
|
Automated Systems for Solid Phase Red Cell Adherence Assays |
|
|
213 | (1) |
|
|
214 | (1) |
|
Solid Phase Red Cell Adherence Assays |
|
|
215 | (1) |
|
SolidscreenR II Technology |
|
|
216 | (1) |
|
|
217 | (3) |
|
Automated System for Gel Technology Assays |
|
|
220 | (6) |
|
PART IV CLINICAL CONSIDERATIONS IN IMMUNOHEMATOLOGY |
|
|
|
Chapter 10 Adverse Complications of Transfusions |
|
|
226 | (20) |
|
Section 1 Overview Of Adverse Reactions To Transfusion |
|
|
227 | (1) |
|
|
227 | (1) |
|
Recognition of a Transfusion Reaction |
|
|
227 | (1) |
|
Section 2 Categories Of Transfusion Reactions |
|
|
228 | (10) |
|
Hemolytic Transfusion Reaction |
|
|
228 | (1) |
|
Acute Hemolytic Transfusion Reaction |
|
|
228 | (2) |
|
Delayed Hemolytic Reaction |
|
|
230 | (1) |
|
Non-Immune-Mediated Mechanisms of Red Cell Destruction |
|
|
231 | (1) |
|
Delayed Serologic Transfusion Reactions |
|
|
232 | (1) |
|
Febrile Nonhemolytic Transfusion Reactions |
|
|
233 | (1) |
|
Allergic and Anaphylactic Transfusion Reactions |
|
|
234 | (1) |
|
Transfusion-Related Acute Lung Injury |
|
|
234 | (1) |
|
Transfusion-Associated Graft-versus-Host Disease |
|
|
235 | (1) |
|
Bacterial Contamination of Blood Products |
|
|
236 | (1) |
|
Transfusion-Associated Circulatory Overload |
|
|
237 | (1) |
|
Transfusion Hemosiderosis |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
238 | (1) |
|
Section 3 Evaluation And Reporting A Transfusion Reaction |
|
|
238 | (8) |
|
Initiating a Transfusion Reaction Investigation |
|
|
238 | (2) |
|
Additional Laboratory Testing in a Transfusion Reaction |
|
|
240 | (1) |
|
Records and Reporting of Transfusion Reactions and Fatalities |
|
|
241 | (1) |
|
|
241 | (1) |
|
|
241 | (1) |
|
FDA Reportable Fatalities |
|
|
241 | (5) |
|
Chapter 11 Hemolytic Disease of the Fetus and Newborn |
|
|
246 | (21) |
|
Section 1 Etiology Of Hemolytic Disease Of The Fetus And Newborn |
|
|
247 | (1) |
|
Section 2 Overview Of Hemolytic Disease Of The Fetus And Newborn |
|
|
247 | (3) |
|
Rh Hemolytic Disease of the Fetus and Newborn |
|
|
248 | (1) |
|
ABO Hemolytic Disease of the Fetus and Newborn |
|
|
249 | (1) |
|
Alloantibodies Causing Hemolytic Disease of the Fetus and Newborn Other than Anti-D |
|
|
249 | (1) |
|
Section 3 Prediction Of Hemolytic Disease Of The Fetus And Newborn |
|
|
250 | (3) |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
253 | (1) |
|
Section 4 Postpartum Testing |
|
|
253 | (2) |
|
Postpartum Testing of Infants and Mothers |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
255 | (1) |
|
|
255 | (1) |
|
Intrauterine Transfusions |
|
|
255 | (1) |
|
Section 5 Prevention Of Hemolytic Disease Of The Fetus And Newborn |
|
|
255 | (3) |
|
Antepartum Administration of Rh Immune Globulin |
|
|
256 | (1) |
|
Postpartum Administration of Rh Immune Globulin |
|
|
256 | (1) |
|
Screening for Fetomaternal Hemorrhage |
|
|
257 | (1) |
|
Quantifying Fetomatemal Hemorrhage |
|
|
258 | (1) |
|
Section 6 Treatment Of Hemolytic Disease Of The Fetus And Newborn |
|
|
258 | (9) |
|
|
258 | (1) |
|
|
259 | (1) |
|
|
259 | (1) |
|
|
259 | (1) |
|
Selection of Blood and Compatibility Testing for Exchange Transfusion |
|
|
260 | (7) |
|
PART V BLOOD COLLECTION AND TESTING |
|
|
|
Chapter 12 Donor Selection and Phlebotomy |
|
|
267 | (19) |
|
Section 1 Donor Screening |
|
|
268 | (8) |
|
|
268 | (1) |
|
|
268 | (2) |
|
|
270 | (1) |
|
Questions for Protection of the Donor |
|
|
270 | (2) |
|
Questions for Protection of the Recipient |
|
|
272 | (3) |
|
|
275 | (1) |
|
|
275 | (1) |
|
Hemoglobin or Hematocrit Determination |
|
|
275 | (1) |
|
|
275 | (1) |
|
|
275 | (1) |
|
|
275 | (1) |
|
|
275 | (1) |
|
|
276 | (1) |
|
|
276 | (3) |
|
|
276 | (1) |
|
|
276 | (1) |
|
Arm Preparation and Venipuncture |
|
|
277 | (1) |
|
|
277 | (1) |
|
Postdonation Instructions and Care |
|
|
277 | (2) |
|
Section 3 Special Blood Collection |
|
|
279 | (7) |
|
|
279 | (1) |
|
|
279 | (1) |
|
Normovolemic Hemodilution |
|
|
280 | (1) |
|
|
280 | (1) |
|
|
280 | (1) |
|
|
281 | (1) |
|
|
281 | (5) |
|
Chapter 13 Testing of Donor Blood |
|
|
286 | (18) |
|
Section 1 Overview Of Donor Blood Testing |
|
|
286 | (1) |
|
Required Testing on Allogeneic and Autologous Donor Blood |
|
|
287 | (1) |
|
Section 2 Immunohematologic Testing Of Donor Units |
|
|
287 | (1) |
|
|
287 | (1) |
|
|
288 | (1) |
|
Section 3 Infectious Disease Testing Of Donor Units |
|
|
288 | (16) |
|
Serologic Tests for Syphilis |
|
|
288 | (1) |
|
|
288 | (1) |
|
Hemagglutination Test for Treponema pallidum Antibodies |
|
|
289 | (1) |
|
Confirmatory Testing for Syphilis |
|
|
289 | (1) |
|
Principles of Viral Marker Testing |
|
|
289 | (1) |
|
Enzyme-Linked Immunosorbent Assay |
|
|
289 | (2) |
|
|
291 | (1) |
|
|
291 | (1) |
|
|
291 | (1) |
|
Sensitivity and Specificity |
|
|
292 | (1) |
|
|
292 | (1) |
|
|
292 | (2) |
|
|
294 | (1) |
|
|
295 | (1) |
|
Human Immunodeficiency Virus Types 1 and 2 |
|
|
296 | (1) |
|
Nucleic Acid Testing for Ribonucleic Acid of Human Immunodeficiency Virus Type 1 |
|
|
297 | (1) |
|
Human T-Lymphotropic Virus Types I and II |
|
|
297 | (1) |
|
|
297 | (1) |
|
|
298 | (1) |
|
Recipient Tracing (Look-Back) |
|
|
299 | (1) |
|
Additional Tests Performed on Donor Blood |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
299 | (1) |
|
Testing for Bacterial Contamination of Blood Components |
|
|
300 | (4) |
|
PART VI BLOOD COMPONENT PREPARATION AND TRANSFUSION THERAPY |
|
|
|
Chapter 14 Blood Component Preparation and Therapy |
|
|
304 | (25) |
|
Section 1 Blood Collection And Storage |
|
|
305 | (4) |
|
|
306 | (1) |
|
Types of Anticoagulant-Preservative Solutions |
|
|
307 | (1) |
|
|
307 | (1) |
|
|
308 | (1) |
|
Section 2 Blood Component Preparation |
|
|
309 | (12) |
|
|
311 | (1) |
|
|
311 | (1) |
|
Red Blood Cell Components |
|
|
311 | (1) |
|
|
311 | (1) |
|
Red Blood Cells Leukocytes Reduced |
|
|
312 | (1) |
|
Apheresis Red Blood Cells |
|
|
313 | (1) |
|
|
314 | (1) |
|
Deglycerolized Red Blood Cells |
|
|
314 | (1) |
|
|
315 | (1) |
|
Red Blood Cells Irradiated |
|
|
315 | (1) |
|
|
316 | (1) |
|
|
316 | (1) |
|
|
317 | (1) |
|
|
317 | (1) |
|
|
317 | (1) |
|
Platelets Leukocytes Reduced |
|
|
318 | (1) |
|
|
318 | (1) |
|
Fresh Frozen Plasma, Plasma Frozen within 24 Hours of Phlebotomy |
|
|
318 | (1) |
|
Cryoprecipitated Antihemophilic Factor |
|
|
319 | (2) |
|
|
321 | (1) |
|
Section 3 Distribution And Administration |
|
|
321 | (8) |
|
|
321 | (2) |
|
Storage and Transportation |
|
|
323 | (1) |
|
Transportation of Blood Components |
|
|
323 | (1) |
|
Administration of Blood Components |
|
|
324 | (5) |
|
Chapter 15 Transfusion Therapy in Selected Patients |
|
|
329 | (16) |
|
Section 1 Transfusion Practices |
|
|
329 | (12) |
|
Urgent and Massive Transfusion |
|
|
329 | (1) |
|
|
330 | (1) |
|
Neonatal and Pediatric Transfusion Issues |
|
|
331 | (1) |
|
|
332 | (1) |
|
|
333 | (1) |
|
Hematopoietic Progenitor Cell Transplantation |
|
|
333 | (2) |
|
|
335 | (1) |
|
|
336 | (1) |
|
|
337 | (1) |
|
Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura |
|
|
338 | (1) |
|
Anemias Requiring Transfusion Support |
|
|
339 | (1) |
|
|
339 | (1) |
|
|
339 | (1) |
|
|
340 | (1) |
|
|
340 | (1) |
|
Section 2 Alternatives To Transfusion |
|
|
341 | (4) |
|
PART VII QUALITY AND SAFETY ISSUES |
|
|
|
Chapter 16 Quality Assurance and Regulation of the Blood Industry and Safety Issues in the Blood Bank |
|
|
345 | (20) |
|
Section 1 Regulatory And Accrediting Agencies For Quality And Safety |
|
|
346 | (2) |
|
Food and Drug Administration |
|
|
346 | (1) |
|
|
347 | (1) |
|
|
347 | (1) |
|
Occupational Safety and Health Act |
|
|
347 | (1) |
|
Environmental Protection Agency |
|
|
347 | (1) |
|
Section 2 Quality Assurance And Good Manufacturing Practices |
|
|
348 | (8) |
|
|
348 | (1) |
|
Quality Assurance Department |
|
|
348 | (1) |
|
Good Manufacturing Practices |
|
|
348 | (1) |
|
Components of a Quality Assurance Program |
|
|
348 | (1) |
|
|
348 | (3) |
|
Standard Operating Procedures |
|
|
351 | (1) |
|
|
352 | (1) |
|
|
352 | (2) |
|
|
354 | (1) |
|
|
354 | (1) |
|
|
355 | (1) |
|
|
355 | (1) |
|
|
355 | (1) |
|
|
356 | (1) |
|
|
356 | (9) |
|
Standard versus Universal Precautions |
|
|
356 | (1) |
|
Blood Bank Safety Program |
|
|
356 | (1) |
|
Physical Space, Safety Equipment, Protective Devices, and Warning Signs |
|
|
357 | (2) |
|
|
359 | (1) |
|
Chemical Storage and Hazards |
|
|
359 | (1) |
|
|
359 | (1) |
|
|
359 | (1) |
|
Storage and Transportation of Blood and Blood Components |
|
|
360 | (1) |
|
Personal Injury and Reporting |
|
|
360 | (1) |
|
|
360 | (5) |
Appendix A Answers To Study Questions |
|
365 | (2) |
Glossary |
|
367 | (6) |
Index |
|
373 | |